WNK kinases, renal ion transport and hypertension

American Journal of Nephrology

Volumn 28, Issue 5, 2008, Pages 860-870

  San Cristobal, Pedro ^a   De Los Heros, Paola ^a   Ponce Coria, José ^a   Moreno, Erika ^a,b   Gamba, Gerardo ^a,c  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DEL ESTADO DE HIDALGO   (Mexico)

^c Molecular Physiology Unit   (Mexico)

Author keywords

Distal convoluted tubule; Diuretics; Phosphorylation; Potassium excretion; Salt transport

Indexed keywords

ALDOSTERONE; PROTEIN KINASE WNK1; PROTEIN KINASE WNK4; SODIUM CHLORIDE COTRANSPORTER;

ARTERIAL PRESSURE; BLOOD PRESSURE; GENE DELETION; GENE MUTATION; GITELMAN SYNDROME; HUMAN; HYPERKALEMIA; HYPERTENSION; ION TRANSPORT; KIDNEY TUBULE ABSORPTION; METABOLIC ACIDOSIS; NONHUMAN; POTASSIUM EXCRETION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PSEUDOHYPOALDOSTERONISM; REVIEW;

HUMANS; HYPERTENSION; ION TRANSPORT; KIDNEY; NEPHRONS; PROTEIN-SERINE-THREONINE KINASES;

EID: 51149104842     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000139639     Document Type: Review

References (68)

1. Guyton AC: Blood pressure control - special role of the kidneys and body fluids. Science 1991;252:1813-1816.
2. Lifton RP, Gharavi AG, Geller DS: Molecular mechanisms of human hypertension. Cell 2001;104:545-556.
3. Simon DB, Nelson-Williams C, Johnson-Bia M, Ellison D, Karet FE, Morey-Molina A, Vaara I, Iwata F, Cushner HM, Koolen M, Gainza FJ, Gitelman HJ, Lifton RP: Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 1996;12:24-30.
4. Lemmink HH, van den Heuvel LP, van Dijk HA, Merkx GF, Smilde TJ, Taschner PE, Monnens LA, Hebert SC, Knoers NV: Linkage of Gitelman syndrome to the thiazide-sensitive sodium-chloride cotransporter gene with identification of mutations in Dutch families. Pediatr Nephrol 1996;10:403-407.
5. Mastroianni N, Bettinelli A, Bianchetti M, Colussi G, de Fusco M, Sereni F, Ballabio A, Casari G: Novel molecular variants of the Na-Cl cotransporter gene are responsible for Gitelman syndrome. Am J Hum Genet 1996;59:1019-1026.
6. Kunchaparty S, Palcso M, Berkman J, Zquez H, Desir GV, Bernstein P, Reilly RF, Ellison DH: Defective processing and expression of thiazide-sensitive Na-Cl cotransporter as a cause of Gitelman's syndrome. Am J Physiol 1999;277:F643-F649.
7. De Jong JC, Van der Vliet WA, van den Heuvel LP, Willems PH, Knoers NV, Bindels RJ: Functional expression of mutations in the human NaCl cotransporter: evidence for impaired routing mechanisms in Gitelman's syndrome. J Am Soc Nephrol 2002;13:1442-1448.
8. Sabath E, Meade P, Berkman J, de los Heros P, Moreno E, Bobadilla NA, Vazquez N, Ellison DH, Gamba G: Pathophysiology of functional mutations of the thiazide-sensitive Na-Cl cotransporter in Gitelman disease. Am J Physiol Renal Physiol 2004;287:F195-F203.
9. Mayan H, Vered I, Mouallem M, Tzadok-Witkon M, Pauzner R, Farfel Z: Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density. J Clin Endocrinol Metab 2002;87:3248-3254.
10. Simon DB, Farfel Z, Ellison D, Bia M, Tucci J, Lifton RP: Examination of the thiazide-sensitive Na-Cl cotransporter as a candidate gene in Gordon's syndrome. 1995, p 632.
11. Mansfield TA, Simon DB, Farfel Z, Bia M, Tucci JR, Lebel M, Gutkin M, Vialettes B, Christofilis MA, Kauppinen-Makelin R, Mayan H, Risch N, Lifton RP: Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21. Nat Genet 1997;16:202-205.
12. Disse-Nicodeme S, Achard JM, Desitter I, Houot AM, Fournier A, Corvol P, Jeunemaitre X: A new locus on chromosome 12p13.3 for pseudohypoaldosteronism type II, an autosomal dominant form of hypertension. Am J Hum Genet 2000;67:302-310.
13. Disse-Nicodeme S, Desitter I, Fiquet-Kempf B, Houot AM, Stern N, Delahousse M, Potier J, Ader JL, Jeunemaitre X: Genetic heterogeneity of familial hyperkalaemic hypertension. J Hypertens 2001;19:1957-1964.
14. Xu B, English JM, Wilsbacher JL, Stippec S, Goldsmith EJ, Cobb MH: WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II. J Biol Chem 2000;275:16795-16801.
15. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard JM, Feely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, Lifton RP: Human hypertension caused by mutations in WNK kinases. Science 2001;293:1107-1112.
16. Delaloy C, Lu J, Houot AM, Disse-Nicodeme S, Gasc JM, Corvol P, Jeunemaitre X: Multiple promoters in the WNK1 gene: one controls expression of a kidney-specific kinasedefective isoform. Mol Cell Biol 2003;23:9208-9221.
17. Golbang AP, Murthy M, Hamad A, Liu CH, Cope G, Hoff WV, Cuthbert A, O'Shaughnessy KM: A new kindred with pseudohypoaldosteronism type II and a novel mutation (564D ] H) in the acidic motif of the WNK4 gene. Hypertension 2005;46:295-300.
18. Min X, Lee BH, Cobb MH, Goldsmith EJ: Crystal structure of the kinase domain of WNK1, a kinase that causes a hereditary form of hypertension. Structure (Camb) 2004;12:1303-1311.
19. Yang CL, Ellison DH: WNK1 interacts physically with WNK4. J Am Soc Nephrol 2003;14:77A.
20. Yang CL, Zhu X, Wang Z, Subramanya AR, Ellison DH: Mechanisms of WNK1 and WNK4 interaction in the regulation of thiazide-sensitive NaCl cotransport. J Clin Invest 2005;115:1379-1387.
21. Yang CL, Zhu X, Ellison DH: The thiazidesensitive Na-Cl cotransporter is regulated by a WNK kinase signaling complex. J Clin Invest 2007;117:3403-3411.
22. Xu BE, Min X, Stippec S, Lee BH, Goldsmith EJ, Cobb MH: Regulation of WNK1 by an autoinhibitory domain and autophosphorylation. J Biol Chem 2002;277:48456-48462.
23. Xu BE, Stippec S, Lenertz L, Lee BH, Zhang W, Lee YK, Cobb MH: WNK1 activates ERK5 by an MEKK2/3-dependent mechanism. J Biol Chem 2004;279:7826-7831.
24. Moniz S, Verissimo F, Matos P, Brazao R, Silva E, Kotevelets L, Chastre E, Gespach C, Jordan P: Protein kinase WNK2 inhibits cell proliferation by negatively modulating the activation of MEK1/ERK1/2. Oncogene 2007;26:6071-6081.
25. Lee BH, Chen W, Stippec S, Cobb MH: Biological cross-talk between WNK1 and the transforming growth factor beta-Smad signaling pathway. J Biol Chem 2007;282:17985-17996.
26. Lee BH, Min X, Heise CJ, Xu BE, Chen S, Shu H, Luby-Phelps K, Goldsmith EJ, Cobb MH: WNK1 phosphorylates synaptotagmin 2 and modulates its membrane binding. Mol Cell 2004;15:741-751.
27. Piechotta K, Lu J, Delpire E: Cation chloride cotransporters interact with the stress-related kinases Ste20-related proline-alaninerich kinase (SPAK) and oxidative stress response 1 (OSR1). J Biol Chem 2002;277:50812-50819.
28. - cotransporters is modulated by the interaction of two kinases: Ste20-related proline-alanine-rich kinase and WNK4. Am J Physiol Cell Physiol 2006;290:C134-C142.
29. Vitari AC, Deak M, Morrice NA, Alessi DR: The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome, phosphorylate and active SPAK and OSR1 protein kinases. Biochem J 2005;391:17-24.
30. Vitari AC, Thastrup J, Rafiqi FH, Deak M, Morrice NA, Karlsson HK, Alessi DR: Functional interactions of the SPAK/OSR1 kinases with their upstream activator WNK1 and downstream substrate NKCC1. Biochem J 2006;397:223-231.
31. Moriguchi T, Urushiyama S, Hisamoto N, Iemura S, Uchida S, Natsume T, Matsumoto K, Shibuya H: WNK1 regulates phosphorylation of cation-chloride- coupled cotransporters via the STE20-related kinases, SPAK and OSR1. J Biol Chem 2005;280:42685-42693.
32. --transporting epithelia. Proc Natl Acad Sci USA 2003;100:663-668.
33. Verissimo F, Jordan P:WNK kinases, a novel protein kinase subfamily in multi-cellular organisms. Oncogene 2001;20:5562-5569.
34. O'Reilly M, Marshall E, Macgillivray T, Mittal M, Xue W, Kenyon CJ, Brown RW: Dietary electrolyte-driven responses in the renal WNK kinase pathway in vivo. J Am Soc Nephrol 2006;17:2402-2413.
35. Holden S, Cox J, Raymond FL: Cloning, genomic organization, alternative splicing and expression analysis of the human gene WNK3 (PRKWNK3). Gene 2004;335:109-119.
36. - in and out of cells: implications for control of cell volume and neuronal excitability. Proc Natl Acad Sci USA 2005;102:16783-16788.
37. - flux in extrarenal epithelia. Proc Natl Acad Sci USA 2004;101:2064-2069.
38. O'Reilly M, Marshall E, Speirs HJ, Brown RW: WNK1, a gene within a novel blood pressure control pathway, tissue-specifically generates radically different isoforms with and without a kinase domain. J Am Soc Nephrol 2003;14:2447-2456.
39. Gamba G, Saltzberg SN, Lombardi M, Miyanoshita A, Lytton J, Hediger MA, Brenner BM, Hebert SC: Primary structure and functional expression of a cDNA encoding the thiazide-sensitive, electroneutral sodiumchloride cotransporter. Proc Natl Acad Sci USA 1993;90:2749-2753.
40. Brown DD: A tribute to the Xenopus laevis oocyte and egg. J Biol Chem 2004;279:45291-45299.
41. Gamba G: Molecular physiology and pathophysiology of the electroneutral cation-chloride cotransporters. Physiol Rev 2005;85:423-493.
42. Wilson FH, Kahle KT, Sabath E, Lalioti MD, Rapson AK, Hoover RS, Hebert SC, Gamba G, Lifton RP: Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wildtype but not mutant WNK4. Proc Natl Acad Sci USA 2003;100:680-684.
43. Yang CL, Angell J, Mitchell R, Ellison DH: WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Invest 2003;111:1039-1045.
44. Golbang AP, Cope G, Hamad A, Murthy M, Liu CH, Cuthbert AW, O'Shaughnessy KM: Regulation of the expression of the Na/Cl cotransporter (NCCT) by WNK4 and WNK1: evidence that accelerated dynamin-dependent endocytosis is not involved. Am J Physiol Renal Physiol 2006;291:F1369-F1376.
45. Cai H, Cebotaru V, Wang YH, Zhang XM, Cebotaru L, Guggino SE, Guggino WB: WNK4 kinase regulates surface expression of the human sodium chloride cotransporter in mammalian cells. Kidney Int 2006;69:2162-2170.
46. Kahle KT, Wilson FH, Lifton RP: Regulation of diverse ion transport pathways by WNK4 kinase: a novel molecular switch. Trends Endocrinol Metab 2005;16:98-103.
47. He G, Wang HR, Huang SK, Huang CL: Intersectin links WNK kinases to endocytosis of ROMK1. J Clin Invest 2007;117:1078-1087.
48. Lazrak A, Liu Z, Huang CL: Antagonistic regulation of ROMK by long and kidney-specific WNK1 isoforms. Proc Natl Acad Sci USA 2006;103:1615-1620.
49. + channel in vitro and in vivo. Proc Natl Acad Sci USA 2007;104:4020-4024.
50. Yamauchi K, Rai T, Kobayashi K, Sohara E, Suzuki T, Itoh T, Suda S, Hayama A, Sasaki S, Uchida S: Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins. Proc Natl Acad Sci USA 2004;101:4690-4694.
51. - permeability is regulated by WNK4 kinase: insight into normal physiology and hypertension. Proc Natl Acad Sci USA 2004;101:14877-14882.
52. - cotransporters. Am J Physiol Renal Physiol 2007;292:F1197-F1207.
53. Amorim JB, Bailey MA, Musa-Aziz R, Giebisch G, Malnic G: Role of luminal anion and pH in distal tubule potassium secretion. Am J Physiol Renal Physiol 2003;284:F381-F388.
54. Boettger T, Hubner CA, Maier H, Rust MB, Beck FX, Jentsch TJ: Deafness and renal tubular acidosis in mice lacking the K-Cl cotransporter KCC4. Nature 2002;416:874-878.
55. Lenertz LY, Lee BH, Min X, Xu BE, Wedin K, Earnest S, Goldsmith EJ, Cobb MH: Properties of WNK1 and implications for other family members. J Biol Chem 2005;280:26653-26658.
56. Subramanya AR, Yang CL, Zhu X, Ellison DH: Dominant-negative regulation of WNK1 by its kidney-specific kinase-defective isoform. Am J Physiol Renal Physiol 2006;290:F619-F624.
57. Xu BE, Stippec S, Chu PY, Lazrak A, Li XJ, Lee BH, English JM, Ortega B, Huang CL, Cobb MH: WNK1 activates SGK1 to regulate the epithelial sodium channel. Proc Natl Acad Sci USA 2005;102:10315-10320.
58. - cotransporter in the nervous system: evidence for a scaffolding role of the kinase. J Biol Chem 2003;278:52848-52856.
59. Dowd BF, Forbush B: PASK (proline-alanine-rich STE20-related kinase), a regulatory kinase of the Na-K-Cl cotransporter (NKCC1). J Biol Chem 2003;278:27347-27353.
60. Villa F, Goebel J, Rafiqi FH, Deak M, Thastrup J, Alessi DR, van Aalten DM: Structural insights into the recognition of substrates and activators by the OSR1 kinase. EMBO Rep 2007;8:839-845.
61. Zambrowicz BP, Abuin A, Ramirez-Solis R, Richter LJ, Piggott J, Beltrandel Rio H, Buxton EC, Edwards J, Finch RA, Friddle CJ, Gupta A, Hansen G, Hu Y, Huang W, Jaing C, Key BW Jr, Kipp P, Kohlhauff B, Ma ZQ, Markesich D, Payne R, Potter DG, Qian N, Shaw J, Schrick J, Shi ZZ, Sparks MJ, Van Sligtenhorst I, Vogel P, Walke W, Xu N, Zhu Q, Person C, Sands AT: Wnk1 kinase deficiency lowers blood pressure in mice: a genetrap screen to identify potential targets for therapeutic intervention. Proc Natl Acad Sci USA 2003;100:14109-14114.
62. Lalioti MD, Zhang J, Volkman HM, Kahle KT, Hoffmann KE, Toka HR, Nelson-Williams C, Ellison DH, Flavell R, Booth CJ, Lu Y, Geller DS, Lifton RP: Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule. Nat Genet 2006;38:1124-1132.
63. Yang SS, Morimoto T, Rai T, Chiga M, Sohara E, Ohno M, Uchida K, Lin SH, Moriguchi T, Shibuya H, Kondo Y, Sasaki S, Uchida S: Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/+) knockin mouse model. Cell Metab 2007;5:331-344.
64. Pacheco-Alvarez D, San Cristobal P, Meade P, Moreno E, Vazquez N, Munoz E, Diaz A, Juarez ME, Gimenez I, Gamba G: The Na-Cl cotransporter is activated and phosphorylated at the amino terminal domain upon intracellular chloride depletion. J Biol Chem 2006;281:28755-28763.
65. + homeostasis. Proc Natl Acad Sci USA 2007;104:4025-4029.
66. Levy D, De Stefano AL, Larson MG, O'Donnell CJ, Lifton RP, Gavras H, Cupples LA, Myers RH: Evidence for a gene influencing blood pressure on chromosome 17: genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham Heart Study. Hypertension 2000;36:477-483.
67. Newhouse SJ, Wallace C, Dobson R, Mein C, Pembroke J, Farrall M, Clayton D, Brown M, Samani N, Dominiczak A, Connell JM, Webster J, Lathrop GM, Caulfield M, Munroe PB: Haplotypes of the WNK1 gene associate with blood pressure variation in a severely hypertensive population from the British Genetics of Hypertension Study. Hum Mol Genet 2005;14:1805-1814.
68. Tobin MD, Raleigh SM, Newhouse S, Braund P, Bodycote C, Ogleby J, Cross D, Gracey J, Hayes S, Smith T, Ridge C, Caulfield M, Sheehan NA, Munroe PB, Burton PR, Samani NJ: Association of WNK1 gene polymorphisms and haplotypes with ambulatory blood pressure in the general population. Circulation 2005;112:3423-3429.